skip to main content

Tübingen research team develops new strategy against sepsis

30.07.2021 Press Release

Acetate stimulates the body's immune defense – Severe bacterial infections alleviated in mice

Some cases of bloodstream infections are mild, but many have a fatal outcome – the reasons for these differences have remained in the dark despite decades of research. Researchers from the Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI), the Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) at the University of Tübingen and the German Center for Infection Research(DZIF) have now discovered a possible cause and on this basis developed a new experimental strategy to combat bacterial sepsis. The therapeutic approach against life-threatening sepsis does not require the use of antibiotics and instead relies on stimulating the body's immune defense by administering the active substance acetate.

As a result of a local infection, bacteria can enter the bloodstream, which can lead to life-threatening sepsis (colloquially known as blood poisoning) and septic shock with organ failure. Among the most common causes of such a sepsis are methicillin-resistant Staphylococcus aureus bacteria (MRSA) that have developed resistance to many of the common antibiotics.

The research team led by Professor Andreas Peschel and Dr Dorothee Kretschmer was able to show that the body's immune defense against staphylococci is strengthened by administering the acetic acid salt sodium acetate, enabling the body to cope better with the severe infection. In experiments with mice that received acetate via their drinking water or an injection, the course of bacterial sepsis was significantly improved.

A bacterial infection is fought by our body with the help of white blood cells. The most common white blood cells in the bloodstream are known as neutrophil granulocytes that are able to detect, ingest, and destroy pathogens. On their surface, neutrophils have various pattern recognition molecules, receptors to which bacteria-specific components bind, thus signaling the presence of bacteria. One such component is acetate, formed by many bacteria, especially by invaded pathogens such as Staphylococcus aureus and by intestinal bacteria in the digestion of food. Acetate is detected by the GPR43 receptor on the neutrophils.

Acetat als Aktivator

"In our study, we were able to investigate for the first time in detail the effects of binding the acetate to neutrophils. It seems to be an amplifier that “wakes up” the granulocytes, so to speak, and puts them on alert," Dorothee Kretschmer reports. "Acetate has a regulatory effect through the activation of the GPR43 receptor so that an adequate and targeted endogenous immune response can occur on several levels." If granulocytes are put on alert prior to an infection, they can react more effectively to the invading pathogens. They then migrate faster from the blood to the infection site, ingest more bacteria, and produce oxygen radicals that kill the bacteria. As a result, the bacteria were less able to multiply and distribute to the organs during a subsequent sepsis caused by the bacterium Staphylococcus aureus.

In experiments, the research team demonstrated that acetate injection or the administration of acetate-containing drinking water led to an improved immune response in mice. "In the case of a subsequent sepsis caused by infection with staphylococci, the bacteria could be killed faster and more efficiently, thus preventing a fatal course," Kretschmer explains. “The mice recovered more quickly, evident for instance by a faster weight gain.” As Katja Schlatterer, the study’s lead author from the participating Cluster of Excellence CMFI reports: “Interestingly, we were able to observe the same effect when we administered acetate only after the onset of sepsis. This led in the same way to an improved immune response and infection clearance.” The research team considers it conceivable that acetate could be used in humans for both the prevention and the treatment of sepsis. As they point out, acetate is already being used in the clinical field, for example as an acid-base regulator in infusions, administered in the event of fluid loss, with the compatibility in humans thus already being proven.

The study, published in the journal Communications Biology, involved scientists from the Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI), the Interfaculty Institute of Microbiol-ogy and Infection Medicine Tübingen (IMIT) at the University of Tübingen and the German Center for Infection Research (DZIF).

Publication

Katja Schlatterer, Christian Beck, Ulrich Schoppmeier, Andreas Peschel, Dorothee Kretschmer: Ac-etate sensing by GPR43 alarms neutrophils and protects from severe sepsis. Communications Biology 4:928, https://doi.org/10.1038/s42003-021-02427-0.

Contact

Prof. Dr. Andreas Peschel

University of Tübingen
Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)
Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT)

Tel: +49 7071 29-74636
E-Mail: andreas.peschel@uni-tuebingen.de

 

Press Contact

Leon Kokkoliadis
Public Relations Management

Tel: +49 7071 29-74707
E-Mail: leon.kokkoliadis@uni-tuebingen.de

Related Articles

Power-to-vitamins: microbes produce folate from simple basic ingredients
12.09.2024 Power-to-vitamins: microbes produce folate from simple basic ingredients Press Release
New Podcasts with Hannes Link and Eric Kemen
10.09.2024 New Podcasts with Hannes Link and Eric Kemen CMFI News
CMFI Mediathek Launch
09.09.2024 CMFI Mediathek Launch CMFI News
Nasal microbiome: depriving multi-resistant bugs of iron
05.08.2024 Nasal microbiome: depriving multi-resistant bugs of iron Press Release
Phage lysin compound HY-133: Start of clinical phase I
30.07.2024 Phage lysin compound HY-133: Start of clinical phase I Press Release
Samuel Wagner Elected Vice-President
25.07.2024 Samuel Wagner Elected Vice-President Press Release
"Bakterien – Die heimlichen Herrscher der Welt"
13.07.2024 "Bakterien – Die heimlichen Herrscher der Welt" In the Media

BR

Solving Problems of Today: CMFI Researchers Receive Technology Transfer Award
04.07.2024 Solving Problems of Today: CMFI Researchers Receive Technology Transfer Award CMFI News
New tool maps microbial diversity with unprecedented details
21.06.2024 New tool maps microbial diversity with unprecedented details Press Release
Clinical trial of innovative phage lysin HY-133 initiated
11.06.2024 Clinical trial of innovative phage lysin HY-133 initiated Press Release
"‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds"
04.06.2024 "‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds" In the Media

Forbes

"LuCa" project is funded by Else Kröner-Fresenius Foundation
16.05.2024 "LuCa" project is funded by Else Kröner-Fresenius Foundation CMFI News
“Medizinische Studien für vulnerable Personen: Medizinethiker Prof. Urban Wiesing”
16.05.2024 “Medizinische Studien für vulnerable Personen: Medizinethiker Prof. Urban Wiesing” In the Media

BR2

Iron-sulfur minerals bear witness to earliest life on earth
15.05.2024 Iron-sulfur minerals bear witness to earliest life on earth Press Release
Direkt in der Nase: Antimikrobielles Peptid bekämpft pathogene Bakterien
08.05.2024 Direkt in der Nase: Antimikrobielles Peptid bekämpft pathogene Bakterien Press Release
Andreas Peschel in the ARD podcast "Medizin von morgen" with Eckart v. Hirschausen and Katharina Adick
23.04.2024 Andreas Peschel in the ARD podcast "Medizin von morgen" with Eckart v. Hirschausen and Katharina Adick In the Media

ARD

Peter Loskill receives Ursula M. Händel Animal Welfare Prize from the DFG
16.04.2024 Peter Loskill receives Ursula M. Händel Animal Welfare Prize from the DFG CMFI News
Ruth Ley receives Advanced Grant from the European Research Council
11.04.2024 Ruth Ley receives Advanced Grant from the European Research Council Press Release
Podcast "Bakterien kontrollieren: Gute Bakterien nutzen, böse bekämpfen"
01.04.2024 Podcast "Bakterien kontrollieren: Gute Bakterien nutzen, böse bekämpfen" In the Media

Exzellent erklärt

Decoding new gene functions in the human gut microbiome
26.03.2024 Decoding new gene functions in the human gut microbiome CMFI News
DFG visits CMFI
20.03.2024 DFG visits CMFI CMFI News
Volkswagen Foundation funds project to convert waste into new biomaterials
14.02.2024 Volkswagen Foundation funds project to convert waste into new biomaterials CMFI News
Exploring hidden members in microbial communities
05.02.2024 Exploring hidden members in microbial communities CMFI News
Antibiotics highjack bacterial immunity
19.01.2024 Antibiotics highjack bacterial immunity Press Release
Novel antibiotic substance from the human nose
18.12.2023 Novel antibiotic substance from the human nose Press Release
Unraveling the Impact of Xenobiotics on Gut Microbiota: A High-Throughput Approach under Anaerobic Conditions
13.12.2023 Unraveling the Impact of Xenobiotics on Gut Microbiota: A High-Throughput Approach under Anaerobic Conditions In the Media
"Mikrobiom – Schlüssel zur Gesundheit?"
08.12.2023 "Mikrobiom – Schlüssel zur Gesundheit?" In the Media

Planet Wissen

The Frankenstein molecule: resurrecting an ancient antibiotic to create antibiotics of the future
30.11.2023 The Frankenstein molecule: resurrecting an ancient antibiotic to create antibiotics of the future In the Media

Nature - Behind the paper

Taking antibiotics back in time
30.11.2023 Taking antibiotics back in time Press Release
Welche Rolle spielen Darmbakterien bei der Krebsimmuntherapie?
23.11.2023 Welche Rolle spielen Darmbakterien bei der Krebsimmuntherapie? Press Release